Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

146 insider filings · Latest: Jun 18, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 19, 2026Mar 20 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$528.83$5.0M40,513(D)

View →

Mar 18, 2026Mar 19 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$529.59$5.0M40,513(D)

View →

Mar 19, 2026Mar 19 8:30 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$529.95$4.4M45,172(D)

View →

Mar 19, 2026Mar 19 8:05 PMPAUL MAHON
Proposed Sale
8,300$529.95$4.4M

View →

Mar 17, 2026Mar 18 8:33 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$536.75$5.1M40,513(D)

View →

Mar 16, 2026Mar 17 9:11 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$533.90$5.1M40,513(D)

View →

Mar 17, 2026Mar 17 8:56 PMJan MalcolmDirector
Sale
45$533.51$24.0K125(D)

View →

Mar 17, 2026Mar 17 8:05 PMJAN MALCOLM
Proposed Sale
45$533.51$24.0K

View →

Mar 16, 2026Mar 16 10:03 PMJUDY OLIAN
Proposed Sale
200$535.44$107.1K

View →

Mar 16, 2026Mar 16 8:31 PMJudy D. OlianDirector
Sale
200$535.44$107.1K4,445(D)

View →

Mar 13, 2026Mar 16 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$538.00$5.1M130(D)

View →

Mar 16, 2026Mar 16 12:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
516$534.99$276.1K8,414(D)

View →

Mar 12, 2026Mar 16 12:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
8,984$537.97$4.8M130(D)

View →

Mar 11, 2026Mar 11 11:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$539.54$5.1M130(D)

View →

Mar 10, 2026Mar 11 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$539.71$5.1M130(D)

View →

Mar 9, 2026Mar 10 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$518.03$4.9M130(D)

View →

Mar 6, 2026Mar 10 8:33 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$477.67$4.5M130(D)

View →

Mar 6, 2026Mar 9 8:36 PMJudy D. OlianDirector
Sale
200$510.00$102.0K4,645(D)

View →

Mar 5, 2026Mar 9 8:36 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$484.55$4.6M130(D)

View →

Mar 9, 2026Mar 9 8:04 PMJUDY OLIAN
Proposed Sale
200$510.00$102.0K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 4, 2026Mar 5 9:35 PMTommy G ThompsonDirector
Option Exercise
2,000$101.802,000(D)

View →

Mar 4, 2026Mar 5 9:34 PMChristopher CauseyDirector
Option Exercise
20$119.766,300(D)

View →

Mar 3, 2026Mar 5 9:33 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03221,000(D)

View →

Mar 2, 2026Mar 3 9:31 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03230,500(D)

View →

Mar 15, 2023Feb 26 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Grant/Award
66,551$217.508,895(D)

View →

Mar 15, 2023Feb 26 9:31 PMMartine A RothblattDirector, Chairperson & CEO
Grant/Award
277,299$217.5037,080(D)

View →

Mar 15, 2023Feb 26 9:30 PMMichael BenkowitzPRESIDENT AND COO
Grant/Award
133,102$217.5017,790(D)

View →

Mar 15, 2023Feb 26 9:30 PMJames EdgemondCFO AND TREASURER
Grant/Award
77,648$217.5010,380(D)

View →

Feb 25, 2026Feb 25 9:31 PMChristopher CauseyDirector
Option Exercise
1,000$119.766,320(D)

View →

Feb 23, 2026Feb 24 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,440$146.030(I)

View →

Feb 19, 2026Feb 19 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0341,800(D)

View →

Feb 17, 2026Feb 18 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.035,065(I)

View →

Feb 9, 2026Feb 10 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0312,940(I)

View →

Feb 5, 2026Feb 5 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0350,100(D)

View →

Feb 2, 2026Feb 3 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0320,815(I)

View →

Jan 26, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0328,690(I)

View →

Jan 20, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
7,875$146.0336,565(I)

View →

Jan 20, 2026Jan 28 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,625$146.0367,875(I)

View →

Jan 21, 2026Jan 23 9:32 PMKevin TraceyDirector
Grant/Award
1,2201,220(D)

View →

← Previous

Page 7 of 7